Skip to main content

Advertisement

Log in

Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB)

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Objective

Current therapies often have limited efficacy and untenable side effects when used to treat persistent incisional pain following cancer-related surgery. Lidocaine patches reduce neuropathic pain from herpes zoster but their benefits for persistent cancer-related postsurgical incisional pain remain unclear.

Study design

Multicenter, double-blind, randomized, two-period crossover trial.

Materials and methods

Twenty-eight cancer patients with postsurgical incisional pain were randomly assigned to receive either lidocaine patches followed by placebo patches or the reverse. Each study period lasted 4 weeks. Patches were applied daily upon waking and left in place for a maximum of 18 h. The primary outcome measure, an 11-point pain intensity rating scale, was administered weekly. Secondary outcomes were administered weekly (Brief Pain Inventory-Short Form(BPI-SF), Subject Global Impression of Change) and at the end of each study period (Short Form-Magill Pain Questionnaire, Linear Analogue Self Assessment Scale, Neuropathy Pain Scale, Pain Catastrophizing Scale, Profile of Mood States Short Form).

Results

Twenty-one patients completed the first period and 18 completed their crossover second phase. No significant intergroup differences were detected in pain intensity ratings. Few secondary end points were significantly different when subjects used the lidocaine versus placebo patches. BPI-SF interference scores were lower in patients using the lidocaine patch during the first study period, including several scores that achieved statistical significance, general activity (p = 0.02), work (p = 0.04), and relations with others (p = 0.02).

Conclusion

Lidocaine patch use did not significantly reduce pain intensity ratings or the majority of related secondary end points in cancer patients with persistent incisional pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Argoff CE (2004) Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale. Curr Med Res Opin 20(Suppl 2):S29–S31. doi:10.1185/030079904X12979

    Article  PubMed  Google Scholar 

  2. Baker F, Denniston M, Zabora J, Polland A, Dudley WN (2002) A POMS short form for cancer patients: psychometric and structural evaluation. Psychooncology 11:273–281. doi:10.1002/pon.564

    Article  PubMed  Google Scholar 

  3. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276:637–639. doi:10.1001/jama.276.8.637

    Article  PubMed  CAS  Google Scholar 

  4. Campbell JN, Raja SN, Meyer RA, Mackinnon SE (1988) Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 32:89–94. doi:10.1016/0304-3959(88)90027-9

    Article  PubMed  CAS  Google Scholar 

  5. Cleeland C et al (1992) How to assess cancer pain. In: Turk DC, Melzack R (eds) Handbook of pain assessment. Guilford, New York, pp 360–387

    Google Scholar 

  6. Coderre TJ, Katz J, Vaccarino AL, Melzack R (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52:259–285. doi:10.1016/0304-3959(93)90161-H

    Article  PubMed  CAS  Google Scholar 

  7. Dajczman E, Gordon A, Kreisman H, Wolkove N (1991) Long-term postthoracotomy pain. Chest 99:270–274. doi:10.1378/chest.99.2.270

    Article  PubMed  CAS  Google Scholar 

  8. Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM (2003) Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60:1274–1283

    PubMed  CAS  Google Scholar 

  9. Fairclough DPH, Cella D, Bonomi P (1998) Comparison of several model-based methods for analyzing incomplete quality of life data in cancer trials. Stat Med 17:781–796. doi:10.1002/(SICI)1097-0258(19980315/15)17:5/7<781::AID-SIM821>3.0.CO;2-O

    Article  PubMed  CAS  Google Scholar 

  10. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149–158. doi:10.1016/S0304-3959(01)00349-9

    Article  PubMed  CAS  Google Scholar 

  11. Galer BS, Rowbotham MC, Perander J, Friedman E (1999) Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 80:533–538. doi:10.1016/S0304-3959(98)00244-9

    Article  PubMed  CAS  Google Scholar 

  12. Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC (2002) The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 18:297–301. doi:10.1097/00002508-200209000-00004

    Article  PubMed  Google Scholar 

  13. Gammaitoni AR, Alvarez NA, Galer BS (2003) Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol 43:111–117. doi:10.1177/0091270002239817

    Article  PubMed  CAS  Google Scholar 

  14. Hurny C, Bernhard J, Coates A, Peterson HF, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, Collins J, Lindtner J, Goldhirsch A, Senn HJ (1996) Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial. Med Care 34:234–248. doi:10.1097/00005650-199603000-00004

    Article  PubMed  CAS  Google Scholar 

  15. Jensen MP, Karoly P, Braver S (1986) The measurement of clinical pain intensity: a comparison of six methods. Pain 27:117–126. doi:10.1016/0304-3959(86)90228-9

    Article  PubMed  CAS  Google Scholar 

  16. Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS (2005) Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain 6:98–106. doi:10.1016/j.jpain.2004.11.002

    Article  PubMed  Google Scholar 

  17. Johansson A, Kornfalt J, Nordin L, Svensson L, Ingvar C, Lundberg J (2003) Wound infiltration with ropivacaine and fentanyl: effects on postoperative pain and PONV after breast surgery. J Clin Anesth 15:113–118. doi:10.1016/S0952-8180(02)00511-1

    Article  PubMed  CAS  Google Scholar 

  18. Karmakar MK, Ho AM (2004) Postthoracotomy pain syndrome. Thorac Surg Clin 14:345–352. doi:10.1016/S1547-4127(04)00022-2

    Article  PubMed  Google Scholar 

  19. Katz J, McCartney CJ (2002) Current status of pre-emptive analgesia. Curr Opin Anaesthesiol 15:435–441. doi:10.1097/00001503-200208000-00005

    Article  PubMed  Google Scholar 

  20. Kehlet H, Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367:1618–1625. doi:10.1016/S0140-6736(06)68700-X

    Article  PubMed  Google Scholar 

  21. Loprinzi CL, Kugler JW, Sloan JA, Rooke TW, Quella SK, Novotny P, Mowat RB, Michalak JC, Stella PJ, Levitt R, Tschetter LK, Windschitl H (1999) Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med 340:346–350. doi:10.1056/NEJM199902043400503

    Article  PubMed  CAS  Google Scholar 

  22. Lussier D, Huskey AG, Portenoy RK (2004) Adjuvant analgesics in cancer pain management. Oncologist 9:571–591. doi:10.1634/theoncologist.9-5-571

    Article  PubMed  CAS  Google Scholar 

  23. Macdonald L, Bruce J, Scott NW, Smith WC, Chambers WA (2005) Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 92:225–230

    PubMed  CAS  Google Scholar 

  24. Malenka RC (1991) The role of postsynaptic calcium in the induction of long-term potentiation. Mol Neurobiol 5:289–295. doi:10.1007/BF02935552

    Article  PubMed  CAS  Google Scholar 

  25. Mandrekar JSD, Novotny PJ, Slaon JA (1999) A general Gibbs sampling algorithm for analyzing linear models using the SAS system. In: Proceedings of the SUGI, p 1644–1649

  26. Mandrekar JSD, Novotny PJ, Slaon JA (1999) A general Gibbs sampling algorithm for analyzing linear models using the SAS system. SUGI Proc 24:1644–1649

    Google Scholar 

  27. Melzack R (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain 1:277–299. doi:10.1016/0304-3959(75)90044-5

    Article  PubMed  CAS  Google Scholar 

  28. Melzack R (1987) The short-form McGill pain questionnaire. Pain 30:191–197. doi:10.1016/0304-3959(87)91074-8

    Article  PubMed  CAS  Google Scholar 

  29. Nguyen A, Girard F, Boudreault D, Fugere F, Ruel M, Moumdjian R, Bouthilier A, Caron JL, Bojanowski MW, Girard DC (2001) Scalp nerve blocks decrease the severity of pain after craniotomy. Anesth Analg 93:1272–1276. doi:10.1097/00000539-200111000-00048

    Article  PubMed  CAS  Google Scholar 

  30. Osman A, Barrios FX, Kopper BA, Hauptmann W, Jones J, O’Neill E (1997) Factor structure, reliability, and validity of the Pain Catastrophizing Scale. J Behav Med 20:589–605. doi:10.1023/A:1025570508954

    Article  PubMed  CAS  Google Scholar 

  31. Pergolizzi J, Boger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P (2008) Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 8:287–313. doi:10.1111/j.1533-2500.2008.00204.x

    Article  PubMed  Google Scholar 

  32. Pocock SJ, Simon R (1975) Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103–115. doi:10.2307/2529712

    Article  PubMed  CAS  Google Scholar 

  33. Reuben SS (2007) Chronic pain after surgery: what can we do to prevent it. Curr Pain Headache Rep 11:5–13. doi:10.1007/s11916-007-0015-9

    Article  PubMed  Google Scholar 

  34. Rowbotham MC, Davies PS, Verkempinck C, Galer BS (1996) Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 65:39–44. doi:10.1016/0304-3959(95)00146-8

    Article  PubMed  CAS  Google Scholar 

  35. Senn S (1993) Cross-over trials in clinical research. Wiley, New York

    Google Scholar 

  36. Sloan JA, Dueck A (2004) Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials. J Biopharm Stat 14:73–96. doi:10.1081/BIP-120028507

    Article  PubMed  CAS  Google Scholar 

  37. Sloan JANP, Lorinzi CL, Nair S (1997) Graphical and analytical tools for the analysis two-period crossover clinical trials. SUGI Proc 22:1312–1317

    Google Scholar 

  38. Sloan JA OFJ, Suman VJ, Sargeant DJ (1998) Incorporating quality of life measurement in oncology clinical trials. In: Proceedings of the American Statistical Association, p 281–287

  39. Wallace MS, Wallace AM, Lee J, Dobke MK (1996) Pain after breast surgery: a survey of 282 women. Pain 66:195–205. doi:10.1016/0304-3959(96)03064-3

    Article  PubMed  CAS  Google Scholar 

  40. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA (2005) Gabapentin for acute and chronic pain. Cochrane Database Syst Rev CD005452

  41. Wiffen PJ, McQuay HJ, Moore RA (2005) Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev CD005451

  42. Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288:1765–1769. doi:10.1126/science.288.5472.1765

    Article  PubMed  CAS  Google Scholar 

  43. Yaksh TL (2006) Calcium channels as therapeutic targets in neuropathic pain. J Pain 7:S13–S30. doi:10.1016/j.jpain.2005.09.007

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charles L. Loprinzi.

Additional information

This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic and was supported in part by Public Health Service grants CA-25224, CA-37404, CA-35103, CA-35119, CA-35415, and CA-35113.

Additional participating institutions include: Medcenter One Health Systems, Bismarck, ND 58501, USA (Edward J. Wos, M.D.); Illinois Oncology Research Assn. CCOP, Peoria, IL 61615-7828, USA (John W. Kugler, M.D.); Abbott Northwestern Hospital, Minneapolis, MN 55407, USA (Daniel M. Anderson, M.D.); Siouxland Hematology–Oncology Associates, Sioux City, IA 51105, USA (Donald B. Wender, M.D.)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheville, A.L., Sloan, J.A., Northfelt, D.W. et al. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB). Support Care Cancer 17, 451–460 (2009). https://doi.org/10.1007/s00520-008-0542-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-008-0542-x

Keywords

Navigation